nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—Thyroid disorder—Varenicline—nicotine dependence	0.0639	0.118	CcSEcCtD
Amiodarone—Pleurisy—Varenicline—nicotine dependence	0.043	0.0793	CcSEcCtD
Amiodarone—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0202	0.0373	CcSEcCtD
Amiodarone—Sleep disturbance—Varenicline—nicotine dependence	0.0187	0.0345	CcSEcCtD
Amiodarone—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0159	0.0425	CbGpPWpGaD
Amiodarone—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0139	0.0257	CcSEcCtD
Amiodarone—Scotoma—Varenicline—nicotine dependence	0.0138	0.0255	CcSEcCtD
Amiodarone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0109	0.029	CbGpPWpGaD
Amiodarone—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0108	0.0287	CbGpPWpGaD
Amiodarone—Coordination abnormal—Varenicline—nicotine dependence	0.0107	0.0197	CcSEcCtD
Amiodarone—THRA—cardiovascular system—nicotine dependence	0.0105	0.126	CbGeAlD
Amiodarone—Abnormal dreams—Varenicline—nicotine dependence	0.0104	0.0191	CcSEcCtD
Amiodarone—Salivary hypersecretion—Varenicline—nicotine dependence	0.0102	0.0188	CcSEcCtD
Amiodarone—Nightmare—Varenicline—nicotine dependence	0.0101	0.0187	CcSEcCtD
Amiodarone—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00987	0.0263	CbGpPWpGaD
Amiodarone—Photophobia—Varenicline—nicotine dependence	0.00985	0.0182	CcSEcCtD
Amiodarone—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00971	0.0259	CbGpPWpGaD
Amiodarone—Dry eye—Varenicline—nicotine dependence	0.00969	0.0179	CcSEcCtD
Amiodarone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00893	0.0238	CbGpPWpGaD
Amiodarone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00885	0.0236	CbGpPWpGaD
Amiodarone—Sleep disorder—Varenicline—nicotine dependence	0.0088	0.0162	CcSEcCtD
Amiodarone—Disorientation—Varenicline—nicotine dependence	0.00851	0.0157	CcSEcCtD
Amiodarone—Eczema—Varenicline—nicotine dependence	0.00847	0.0156	CcSEcCtD
Amiodarone—CACNA1H—cardiovascular system—nicotine dependence	0.00843	0.101	CbGeAlD
Amiodarone—Renal failure acute—Varenicline—nicotine dependence	0.00825	0.0152	CcSEcCtD
Amiodarone—Libido decreased—Varenicline—nicotine dependence	0.00821	0.0152	CcSEcCtD
Amiodarone—Hot flush—Varenicline—nicotine dependence	0.00814	0.015	CcSEcCtD
Amiodarone—CACNA2D2—midbrain—nicotine dependence	0.00812	0.0974	CbGeAlD
Amiodarone—Menopausal symptoms—Varenicline—nicotine dependence	0.00807	0.0149	CcSEcCtD
Amiodarone—Atrial fibrillation—Varenicline—nicotine dependence	0.00804	0.0148	CcSEcCtD
Amiodarone—Visual disturbance—Varenicline—nicotine dependence	0.00804	0.0148	CcSEcCtD
Amiodarone—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00778	0.0208	CbGpPWpGaD
Amiodarone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00755	0.0139	CcSEcCtD
Amiodarone—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00735	0.0196	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00734	0.0196	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00713	0.019	CbGpPWpGaD
Amiodarone—Liver function test abnormal—Varenicline—nicotine dependence	0.00703	0.013	CcSEcCtD
Amiodarone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00697	0.0186	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00676	0.018	CbGpPWpGaD
Amiodarone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00674	0.018	CbGpPWpGaD
Amiodarone—Angina pectoris—Varenicline—nicotine dependence	0.00641	0.0118	CcSEcCtD
Amiodarone—Erectile dysfunction—Varenicline—nicotine dependence	0.00606	0.0112	CcSEcCtD
Amiodarone—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00602	0.016	CbGpPWpGaD
Amiodarone—Photosensitivity reaction—Varenicline—nicotine dependence	0.00601	0.0111	CcSEcCtD
Amiodarone—Weight increased—Varenicline—nicotine dependence	0.00599	0.0111	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00582	0.0107	CcSEcCtD
Amiodarone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00553	0.0148	CbGpPWpGaD
Amiodarone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00549	0.0146	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—CHRNB3—nicotine dependence	0.00546	0.0146	CbGpPWpGaD
Amiodarone—Bradycardia—Varenicline—nicotine dependence	0.00536	0.0099	CcSEcCtD
Amiodarone—Hallucination—Varenicline—nicotine dependence	0.00524	0.00968	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—CHRNA6—nicotine dependence	0.00518	0.0138	CbGpPWpGaD
Amiodarone—THRA—brain—nicotine dependence	0.00516	0.0619	CbGeAlD
Amiodarone—THRB—brain—nicotine dependence	0.00516	0.0619	CbGeAlD
Amiodarone—CACNA2D2—brain—nicotine dependence	0.0051	0.0612	CbGeAlD
Amiodarone—Visual impairment—Varenicline—nicotine dependence	0.00508	0.00937	CcSEcCtD
Amiodarone—ADRB1—cardiovascular system—nicotine dependence	0.00501	0.0601	CbGeAlD
Amiodarone—Erythema multiforme—Varenicline—nicotine dependence	0.00498	0.0092	CcSEcCtD
Amiodarone—Tinnitus—Varenicline—nicotine dependence	0.00491	0.00907	CcSEcCtD
Amiodarone—THRB—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0049	0.0131	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00489	0.013	CbGpPWpGaD
Amiodarone—Arrhythmia—Varenicline—nicotine dependence	0.00471	0.00869	CcSEcCtD
Amiodarone—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00469	0.0125	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00469	0.0125	CbGpPWpGaD
Amiodarone—Erythema—Varenicline—nicotine dependence	0.00459	0.00847	CcSEcCtD
Amiodarone—Dysgeusia—Varenicline—nicotine dependence	0.00449	0.00829	CcSEcCtD
Amiodarone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00447	0.0119	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00444	0.0119	CbGpPWpGaD
Amiodarone—Back pain—Varenicline—nicotine dependence	0.00444	0.00819	CcSEcCtD
Amiodarone—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00441	0.0118	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00436	0.0116	CbGpPWpGaD
Amiodarone—Vision blurred—Varenicline—nicotine dependence	0.00432	0.00798	CcSEcCtD
Amiodarone—Tremor—Varenicline—nicotine dependence	0.0043	0.00793	CcSEcCtD
Amiodarone—Ill-defined disorder—Varenicline—nicotine dependence	0.00426	0.00786	CcSEcCtD
Amiodarone—Agitation—Varenicline—nicotine dependence	0.00421	0.00778	CcSEcCtD
Amiodarone—Angioedema—Varenicline—nicotine dependence	0.00419	0.00774	CcSEcCtD
Amiodarone—CACNA1H—brain—nicotine dependence	0.00414	0.0496	CbGeAlD
Amiodarone—Malaise—Varenicline—nicotine dependence	0.00414	0.00763	CcSEcCtD
Amiodarone—Vertigo—Varenicline—nicotine dependence	0.00412	0.00761	CcSEcCtD
Amiodarone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0041	0.0109	CbGpPWpGaD
Amiodarone—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00404	0.0108	CbGpPWpGaD
Amiodarone—Cough—Varenicline—nicotine dependence	0.004	0.00739	CcSEcCtD
Amiodarone—Anxiety—Varenicline—nicotine dependence	0.00389	0.00718	CcSEcCtD
Amiodarone—Discomfort—Varenicline—nicotine dependence	0.00386	0.00712	CcSEcCtD
Amiodarone—KCNH2—cardiovascular system—nicotine dependence	0.00383	0.0459	CbGeAlD
Amiodarone—Dry mouth—Varenicline—nicotine dependence	0.00382	0.00705	CcSEcCtD
Amiodarone—SIGMAR1—midbrain—nicotine dependence	0.00376	0.0451	CbGeAlD
Amiodarone—CACNA2D2—Neuronal System—GABRA4—nicotine dependence	0.00374	0.00999	CbGpPWpGaD
Amiodarone—Oedema—Varenicline—nicotine dependence	0.00374	0.00691	CcSEcCtD
Amiodarone—Infection—Varenicline—nicotine dependence	0.00372	0.00686	CcSEcCtD
Amiodarone—Shock—Varenicline—nicotine dependence	0.00368	0.0068	CcSEcCtD
Amiodarone—Thrombocytopenia—Varenicline—nicotine dependence	0.00366	0.00677	CcSEcCtD
Amiodarone—Tachycardia—Varenicline—nicotine dependence	0.00365	0.00674	CcSEcCtD
Amiodarone—Skin disorder—Varenicline—nicotine dependence	0.00364	0.00671	CcSEcCtD
Amiodarone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00362	0.00967	CbGpPWpGaD
Amiodarone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00362	0.00965	CbGpPWpGaD
Amiodarone—Hyperhidrosis—Varenicline—nicotine dependence	0.00362	0.00668	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—CHRNB4—nicotine dependence	0.00359	0.00957	CbGpPWpGaD
Amiodarone—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00358	0.00955	CbGpPWpGaD
Amiodarone—Anorexia—Varenicline—nicotine dependence	0.00357	0.00659	CcSEcCtD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00355	0.00947	CbGpPWpGaD
Amiodarone—Hypotension—Varenicline—nicotine dependence	0.0035	0.00646	CcSEcCtD
Amiodarone—Insomnia—Varenicline—nicotine dependence	0.00339	0.00625	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—CHRNA5—nicotine dependence	0.00334	0.0089	CbGpPWpGaD
Amiodarone—Dyspnoea—Varenicline—nicotine dependence	0.00334	0.00616	CcSEcCtD
Amiodarone—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00332	0.00886	CbGpPWpGaD
Amiodarone—Dyspepsia—Varenicline—nicotine dependence	0.00329	0.00608	CcSEcCtD
Amiodarone—Decreased appetite—Varenicline—nicotine dependence	0.00325	0.00601	CcSEcCtD
Amiodarone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00323	0.00862	CbGpPWpGaD
Amiodarone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00323	0.00597	CcSEcCtD
Amiodarone—Fatigue—Varenicline—nicotine dependence	0.00323	0.00596	CcSEcCtD
Amiodarone—Pain—Varenicline—nicotine dependence	0.0032	0.00591	CcSEcCtD
Amiodarone—Constipation—Varenicline—nicotine dependence	0.0032	0.00591	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00319	0.00852	CbGpPWpGaD
Amiodarone—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00319	0.00851	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00313	0.00834	CbGpPWpGaD
Amiodarone—CYP2C9—cardiovascular system—nicotine dependence	0.00311	0.0373	CbGeAlD
Amiodarone—Feeling abnormal—Varenicline—nicotine dependence	0.00308	0.00569	CcSEcCtD
Amiodarone—CYP2A6—brain—nicotine dependence	0.00306	0.0367	CbGeAlD
Amiodarone—Gastrointestinal pain—Varenicline—nicotine dependence	0.00306	0.00565	CcSEcCtD
Amiodarone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00305	0.00814	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00305	0.00814	CbGpPWpGaD
Amiodarone—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00301	0.00804	CbGpPWpGaD
Amiodarone—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00301	0.00803	CbGpPWpGaD
Amiodarone—KCNH2—midbrain—nicotine dependence	0.00299	0.0359	CbGeAlD
Amiodarone—Urticaria—Varenicline—nicotine dependence	0.00297	0.00549	CcSEcCtD
Amiodarone—Body temperature increased—Varenicline—nicotine dependence	0.00296	0.00546	CcSEcCtD
Amiodarone—Abdominal pain—Varenicline—nicotine dependence	0.00296	0.00546	CcSEcCtD
Amiodarone—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00289	0.00772	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00284	0.00757	CbGpPWpGaD
Amiodarone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0028	0.00747	CbGpPWpGaD
Amiodarone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00276	0.00737	CbGpPWpGaD
Amiodarone—Hypersensitivity—Varenicline—nicotine dependence	0.00276	0.00509	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—CHRNA3—nicotine dependence	0.00272	0.00726	CbGpPWpGaD
Amiodarone—Asthenia—Varenicline—nicotine dependence	0.00269	0.00496	CcSEcCtD
Amiodarone—Pruritus—Varenicline—nicotine dependence	0.00265	0.00489	CcSEcCtD
Amiodarone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00262	0.00699	CbGpPWpGaD
Amiodarone—Diarrhoea—Varenicline—nicotine dependence	0.00256	0.00473	CcSEcCtD
Amiodarone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0025	0.00666	CbGpPWpGaD
Amiodarone—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00248	0.0066	CbGpPWpGaD
Amiodarone—Dizziness—Varenicline—nicotine dependence	0.00248	0.00457	CcSEcCtD
Amiodarone—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00247	0.00658	CbGpPWpGaD
Amiodarone—ADRB1—brain—nicotine dependence	0.00246	0.0295	CbGeAlD
Amiodarone—THRA—Gene Expression—CCAR1—nicotine dependence	0.00242	0.00644	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—CCAR1—nicotine dependence	0.00242	0.00644	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—CHRNB2—nicotine dependence	0.0024	0.00639	CbGpPWpGaD
Amiodarone—Vomiting—Varenicline—nicotine dependence	0.00238	0.00439	CcSEcCtD
Amiodarone—SIGMAR1—brain—nicotine dependence	0.00236	0.0283	CbGeAlD
Amiodarone—Rash—Varenicline—nicotine dependence	0.00236	0.00436	CcSEcCtD
Amiodarone—Dermatitis—Varenicline—nicotine dependence	0.00236	0.00435	CcSEcCtD
Amiodarone—Headache—Varenicline—nicotine dependence	0.00234	0.00433	CcSEcCtD
Amiodarone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0023	0.00613	CbGpPWpGaD
Amiodarone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00228	0.00608	CbGpPWpGaD
Amiodarone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00227	0.00605	CbGpPWpGaD
Amiodarone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00227	0.00605	CbGpPWpGaD
Amiodarone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00225	0.006	CbGpPWpGaD
Amiodarone—Nausea—Varenicline—nicotine dependence	0.00222	0.0041	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—CHRNA4—nicotine dependence	0.00217	0.0058	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00213	0.00568	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00209	0.00558	CbGpPWpGaD
Amiodarone—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00204	0.00545	CbGpPWpGaD
Amiodarone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00203	0.0054	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00201	0.00535	CbGpPWpGaD
Amiodarone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00195	0.00519	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00193	0.00516	CbGpPWpGaD
Amiodarone—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00193	0.00514	CbGpPWpGaD
Amiodarone—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00192	0.00512	CbGpPWpGaD
Amiodarone—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0019	0.00506	CbGpPWpGaD
Amiodarone—KCNH2—brain—nicotine dependence	0.00188	0.0225	CbGeAlD
Amiodarone—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00186	0.00497	CbGpPWpGaD
Amiodarone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00186	0.00497	CbGpPWpGaD
Amiodarone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00185	0.00493	CbGpPWpGaD
Amiodarone—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00176	0.00471	CbGpPWpGaD
Amiodarone—CYP2C8—brain—nicotine dependence	0.00172	0.0206	CbGeAlD
Amiodarone—ABCB1—cardiovascular system—nicotine dependence	0.00168	0.0201	CbGeAlD
Amiodarone—CYP1A1—brain—nicotine dependence	0.00159	0.019	CbGeAlD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00158	0.00421	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00152	0.00405	CbGpPWpGaD
Amiodarone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0015	0.00401	CbGpPWpGaD
Amiodarone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00148	0.00395	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00148	0.00394	CbGpPWpGaD
Amiodarone—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00148	0.00394	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0014	0.00372	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00139	0.00371	CbGpPWpGaD
Amiodarone—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00137	0.00366	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00134	0.00357	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CYP2A7—nicotine dependence	0.00132	0.00353	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00131	0.00351	CbGpPWpGaD
Amiodarone—ABCB1—midbrain—nicotine dependence	0.00131	0.0157	CbGeAlD
Amiodarone—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0013	0.00346	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00128	0.00341	CbGpPWpGaD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00122	0.00325	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.00122	0.00324	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00121	0.00322	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00119	0.00317	CbGpPWpGaD
Amiodarone—CYP2D6—brain—nicotine dependence	0.00115	0.0137	CbGeAlD
Amiodarone—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00114	0.00304	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00108	0.00287	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00106	0.00283	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00105	0.0028	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00104	0.00278	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00099	0.00264	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000981	0.00262	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000976	0.0026	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000968	0.00258	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000956	0.00255	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CYP2A7—nicotine dependence	0.000943	0.00251	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000889	0.00237	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000838	0.00224	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000836	0.00223	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000827	0.00221	CbGpPWpGaD
Amiodarone—ABCB1—brain—nicotine dependence	0.000824	0.00989	CbGeAlD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000819	0.00218	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000759	0.00202	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000691	0.00184	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000686	0.00183	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000656	0.00175	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000647	0.00173	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000638	0.0017	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000623	0.00166	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000596	0.00159	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000592	0.00158	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000451	0.0012	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000448	0.0012	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000383	0.00102	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000352	0.00094	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000352	0.000938	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000329	0.000878	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.00032	0.000853	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000311	0.000829	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000302	0.000805	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000255	0.000679	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000238	0.000635	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000231	0.000617	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000225	0.0006	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000219	0.000584	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.00021	0.00056	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000206	0.00055	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000189	0.000504	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000184	0.000491	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.00018	0.000479	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000169	0.000451	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000168	0.000447	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000143	0.000382	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000137	0.000364	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000111	0.000295	CbGpPWpGaD
